首页> 外文期刊>Current Science: A Fortnightly Journal of Research >Bio-business in brief: the paradox of being a drug company
【24h】

Bio-business in brief: the paradox of being a drug company

机译:生物商业简述:成为制药公司的悖论

获取原文
获取原文并翻译 | 示例
       

摘要

Companies must show a profit to survive. But medicines should essentially cure people, which would automatically decrease the sale of drugs, thereby decreasing the profits of the drug companies. How does one resolve this contradiction? Currently, manycompanies are pursuing the profit motive first, with health care asa second priority. We list two dozen reasons that could underlie an increase in the revenue for a drug company.About half of them are ethical reasons, and the other half unethical. We discuss some of these reasonswith examples. A change in the drug discovery paradigm may be warranted to resolve this contradiction.
机译:公司必须表现出利润才能生存。但是药品从根本上应该治愈人们,这将自动减少药品的销售,从而降低药品公司的利润。如何解决这一矛盾?当前,许多公司都首先追求利润动机,而医疗保健则是第二优先。我们列出了可能导致制药公司收入增长的两个原因,其中大约一半是出于道德原因,另一半是不道德的原因。我们通过示例讨论其中一些原因。可能需要改变药物发现范式来解决这个矛盾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号